Behrooz Johari (B Johari)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 13

Top Venues

Cell biology international

Journal of cellular physiology

Molecular biology reports

Nanomedicine (London, England)

Zanjan University of Medical Sciences

Pasteur Institute of Iran (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Zanjan University of Medical Sciences Jan 01 2018

Iran

Assistant professor :: Department of medical biotechnology and nanotechnology

Education History

Pasteur Institute of Iran Feb 01 2012 - Jul 02 2017

Iran

PHD :: Department of Biochemistry

Tehran University of Medical Sciences Sep 01 2010 - Jan 15 2012

Iran

MSC :: Department of Medical Biotechnology

Iran University of Medical Sciences Sep 01 2008 - Jun 10 2010

Iran

BSC :: Department of surgical Technology

Publications

Navid Mousazadeh, Mahmoud Gharbavi, Hamid Rashidzadeh, Hamed Nosrati, Hossein Danafar, Behrooz Johari
Anticancer evaluation of methotrexate and curcumin-coencapsulated niosomes against colorectal cancer cell lines. Nanomedicine (London, England) 17 (4) (2022)
Behrooz Johari, F Maghsood, H Madanchi, Mohammad Moradi, M Kadivar
Investigating the anti-inflammatory effects of high molecular weight secretions from Limosilactobacillus reuteri PTCC 1655 on LPS-stimulated PMA-differentiated THP-1 cells. Journal of applied microbiology 131 (2) (2021)
Zoleykha Asadi, Mojtaba Fathi, Elham Rismani, Zahra Bigdelou, Behrooz Johari
Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line. Cell biology international 45 (5) (2021)
Mahmoud Gharbavi, Behrooz Johari, Seyed Sadegh Eslami, Navid Mousazadeh, Ali Sharafi
Cholesterol-conjugated bovine serum albumin nanoparticles as a tamoxifen tumor-targeted delivery system. Cell biology international 44 (12) (2020)
Mohammad Rahmati, Behrooz Johari, Mehdi Kadivar, Elham Rismani, Yousef Mortazavi
Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy. Journal of cellular physiology 235 (6) (2020)
Mahmoud Gharbavi, Behrooz Johari, Elham Rismani, Navid Mousazadeh, Amir Hossein Taromchi, Ali Sharafi
NANOG Decoy Oligodeoxynucleotide-Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme Cells. ACS chemical neuroscience 11 (24) (2020)
Mahmoud Gharbavi, Behrooz Johari, Navid Mousazadeh, Bahareh Rahimi, Milad Parvinzad Leilan, Seyed Sadegh Eslami, Ali Sharafi
Hybrid of niosomes and bio-synthesized selenium nanoparticles as a novel approach in drug delivery for cancer treatment. Molecular biology reports 47 (9) (2020)
Behrooz Johari, Mohammad Rahmati, Leila Nasehi, Yousef Mortazavi, Mohammad Hasan Faghfoori, Hamed Rezaeejam
Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line. Cell biology international 44 (12) (2020)
Zahra Bigdelou, Yousef Mortazavi, Zohreh Saltanatpour, Zoleykha Asadi, Mehdi Kadivar, Behrooz Johari
Role of Oct4-Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cells. Molecular biology reports 47 (3) (2020)
Zohreh Saltanatpour, Behrooz Johari, Akram Alizadeh, Majid Lotfinia, Keivan Majidzadeh-A, Behrooz Nikbin, Mehdi Kadivar
Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line. Journal of cellular physiology 234 (12) (2019)
Leila Saremi, Shirin Lotfıpanah, Masumeh Mohammadi, Hassan Hosseinzadeh, Zahra Hosseini-Khah, Behrooz Johari, Zohreh Saltanatpour
Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus Turkish journal of medical sciences 49 (4) (2019)
Zahra Bigdelou, Behrooz Johari, Mehdi Kadivar, Elham Rismani, Zoleykha Asadi, Mohammad Rahmati, Zohreh Saltanatpour
Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT). Journal of cellular physiology 234 (12) (2019)
Behrooz Johari, Jamil Zargan
Simultaneous targeted inhibition of Sox2-Oct4 transcription factors using decoy oligodeoxynucleotides to repress stemness properties in mouse embryonic stem cells. Cell biology international 41 (12) (2017)

Behrooz Johari.css-eqlu8i{font-size:small;padding-left:4px;} (B Johari)

Publication Activity (10 Years)

Top Topics

Top Venues

Behrooz Johari (B Johari)